
Opinion|Videos|August 7, 2024
Unmet Needs and Future Initiatives
Dr. Tichy discusses unmet needs he deems crucial for the continued uptake of biosimilars.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the unmet needs and future initiatives you see as crucial for the continued uptake of biosimilars?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Value-Based Care Interventions and Management of CKD Progression
5